@dansfera: The debate over real-time clinical data just got heated. While faster access to data sounds like a win for society, the ripple effects on pharma companies and research sites tell a different story. If the ultimate goal is efficiency, does that mean less profit for those actually running the trials? It’s a classic tug-of-war between public health progress and industry incentives. #ClinicalTrials #Pharma #HealthTech #MedicalResearch #DataAnalysis